Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Future Standard of Care Regimens in CLL: Ibrutinib + Venetoclax Combinations & PFS by IGHV Mutation Status
Login to view comments.
Click here to Login
Malignant Hematology